Late 2025Expansion
Acquisition of Quadrel animal health biologicals

Accelerating pharmaceutical technology, companion animal medicine, and specialized veterinary biological formulations.
As part of its international growth program, FATRO completed the acquisition of Quadrel, broadening the scientific scope of its specialized research programs and strengthening international distribution partnerships.